Almousa SS, Ashraf A, Abdelrahman AM, Yacoubi MT (2023) Imaging features of the renal lymphoma: case report and literature review. BJR Case Rep 9(3):20220117

PubMed  PubMed Central  Google Scholar 

Weisenburger DD, Vose JM, Greiner TC, Lynch JC, Chan WC, Bierman PJ et al (2000) Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol 64(3):190–196

Article  CAS  PubMed  Google Scholar 

Bhattacharjee U, Wadhera S, Jain A, Nada R, Sreedharanunni S, Sachdeva MUS et al (2023) Complete renal and haematological remission in a case of mantle cell lymphoma associated paraneoplastic focal segmental glomerulosclerosis with ibrutinib: a case report and review of literature. Annals Lymphoma. 7

Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG et al (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18(5):1476–1485

Article  CAS  PubMed  Google Scholar 

Jain P, Wang ML (2022) Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments. Am J Hematol 97(5):638–656

Article  CAS  PubMed  Google Scholar 

Jain P, Young OKC, Nastoupil LJ, Westin J, Hill HA, Nair R et al (2023) Acalabrutinib with Rituximab as First-Line therapy for older patients with Mantle Cell Lymphoma - a phase II clinical trial. Blood 142(Supplement 1):3036

Article  Google Scholar 

Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M et al (2024) Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. Lancet 403(10441):2293–306

Article  CAS  PubMed  Google Scholar